IL6 and chronic kidney disease: The results show that SQYSF can effectively reduce renal fibrosis in CKD mice, significantly reduce the expression of inflammatory factors TNF-α, IL-1β and IL-6, and can significantly change the composition of the mouse intestinal flora.